Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Dec 30;38(2):176-186.
doi: 10.1515/jpem-2024-0468. Print 2025 Feb 25.

Sialidosis type 1 in a Turkish family: a case report and review of literatures

Mustafa Kılıç  1 , Suzan İcil  1 , Abdullah Sezer  2 , Öznur Kaya-Güneş  2 , Selim S Comoğlu  3
Affiliations
Case Reports

Sialidosis type 1 in a Turkish family: a case report and review of literatures

Mustafa Kılıç et al. J Pediatr Endocrinol Metab. .

Abstract

Objectives: Sialidosis type 1 is a rare autosomal recessive lysosomal storage disorder caused by pathogenic variants in the NEU1 gene, which encodes the sialic acid-degrading enzyme α-neuraminidase. Sialidosis type 1 is a milder form with a late-onset phenotype, characterized by progressive myoclonic epilepsy and ataxia with cherry-red spots. Sialidosis type 2 is an early-onset and more severe form presenting with dysmorphic features, hepatosplenomegaly and cognitive delay. Clinical diagnosis is usually supported by increased urinary bound sialic acid excretion and confirmed by genetic analysis or demonstration of α-neuraminidase enzyme deficiency in cultured fibroblasts. The aim of this study was to present a case of type 1 sialidosis, review the literature, and investigate genotype-phenotype correlations, symptom frequencies, and race-specific mutations in patients diagnosed with type 1 sialidosis.

Case presentation: We report herein a family of four Turkish siblings affected with sialidosis type 1 associated with a homozygous variant, c.403G>A p. (Asp135Asn), in the NEU1 gene. A systematic literature review on sialidosis type 1 was carried out, by the PubMed database was searched using keywords included sialidosis and/or NEU1 gene. We selected case reports or series that included genetically confirmed type 1 sialidosis from 1996 to 2023. So far, nearly genetically confirmed 80 patients from unrelated 65 families, more than 40 NEU1 disease causing mutations, have been identified in patients with sialidosis type 1. Among the reported mutations, missense variants are the most common, and few nonsense, frameshift, exonic duplications or small deletions have been reported. c.239C>T p. (Pro80Leu) variant in Chinese and Japanese patients, c.649G>A p. (Val217Met) variant in Japanese patients, c.880C>T p. (Arg294Cys) variant in Indian patients, c.629C>T p. (Pro210Leu) variant in Ecuadorian patients, c.982G>A p. (Gly328Ser) variant in Italian patients, and c.403G>A p (Asp135Asn) and c.625del p. (Glu209Serfs*94) variants in Turkish patients were found higher.

Conclusions: Race-specific variants were found with higher percentages in certain populations.

Keywords: NEU1; ataxia; cherry-red spots; myoclonus; neuraminidase 1; sialidosis.

PubMed Disclaimer

References

    1. Loren, DJ, Campos, Y, D’Azzo, A, Wyble, L, Grange, DK, Gilbert-Barness, E, et al.. Sialidosis presenting as severe nonimmune fetal hydrops is associated with two novel mutations in lysosomal alpha-neuraminidase. J Perinatol 2005;25:491–4. https://doi.org/10.1038/sj.jp.7211335 . - DOI
    1. McKellar, MJ, Hidajat, RR, Elder, MJ. Acute ocular methanol toxicity: clinical and electrophysiological features. Aust NZ J Ophthalmol 1997;25:225–30. https://doi.org/10.1111/j.1442-9071.1997.tb01397.x . - DOI
    1. Annunziata, I, Patterson, A, Helton, D, Hu, H, Moshiach, S, Gomero, E, et al.. Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-β secretion via deregulated lysosomal exocytosis. Nat Commun 2013;4:2734. https://doi.org/10.1038/ncomms3734 . - DOI
    1. Simon, J, Frits, AW. Glycosaminoglycans and oligosaccharides disorders: glycosaminoglycans synthesis defects, mucopolysaccharidoses, oligosaccharidoses and sialic acid disorders. In: Saudubray, JM, Baumgartner, MR, García-Cazorla, Á, Walter, JH, editors. Inborn Metabolic Diseases Diagnosis and Treatment , 7th ed. Germany: Springer Nature; 2022:778 p.
    1. Yogalingam, G, Bonten, EJ, van de Vlekkert, D, Hu, H, Moshiach, S, Connell, SA, et al.. Neuraminidase 1 is a negative regulator of lysosomal exocytosis. Dev Cell 2008;15:74–86. https://doi.org/10.1016/j.devcel.2008.05.005 . - DOI

Supplementary concepts

LinkOut - more resources